Idexx Laboratories (IDXX) Research & Development (2009 - 2026)

Idexx Laboratories' Research & Development history runs 18 years deep, the most recent figure standing at $175.2 million for Q1 2026.

• In Q1 2026, Research & Development rose 196.73% year-over-year to $175.2 million; the TTM figure through Mar 2026 stood at $174.5 million (down 57.0% YoY), while the FY2025 annual figure was $251.2 million, down 57.31% from the prior year.
• Research & Development for Q1 2026 stood at $175.2 million, up from -$225.3 million in the prior quarter.
• The five-year high for Research & Development was $175.2 million in Q1 2026, with the low at -$225.3 million in Q4 2025.
• The 5-year median for Research & Development is $132.3 million (2022), against an average of $96.3 million.
• The sharpest annual moves came in 2022 and 2025: Research & Development surged 252.04% in 2022, then tumbled 250.08% in 2025.
• Idexx Laboratories' Research & Development stood at $43.4 million in 2022, then jumped by 227.13% to $142.0 million in 2023, then gained by 5.69% to $150.1 million in 2024, then sank by 250.08% to -$225.3 million in 2025, then soared by 177.79% to $175.2 million in 2026.
• Business Quant data shows IDXX's Research & Development at $175.2 million in Q1 2026, -$225.3 million in Q4 2025, and $63.4 million in Q3 2025.